Drugs / Neoantigen Personalized Cancer Vaccine
Neoantigen Personalized Cancer Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07067385 | Jul 2025 → Dec 2027 expected | digestive system neoplasm | Ruijin Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neoantigen Personalized Cancer Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07067385 ↗ |
| Modality | Messenger RNA (mRNA) | “Personalized mRNA Cancer Vaccine” NCT07067385 ↗ |